Isomark Clinical Nutrition Study Presented at ASPEN 2018 Isomark conducted a Phase I trial at the University of Wisconsin utilizing the Canary in a pilot study to assess the feasibility and clinical applicability of the technology in supplementally fed patients. This study was presented at the American Society for Parenteral and Enteral Nutrition (ASPEN) Conference on January 22, 2018 in Las Vegas, NV.
Hello Isomark Friends and Partners, 2017 has proven to be a productive year for the Isomark team. In this newsletter we give an update on the ongoing infection study, introduce an athletic performance study, and discuss the most recent developments made to our device. In addition, this coming fall we are planning to launch our infection detection regulatory trial with the goal of FDA clearance in 2018. Sincerely, Joe Kremer, CEO Infection Study Update How things are progressing. At the start of our human clinical studies we began with a proof-of-concept study. Follow this link to those study results. Since then we expanded the study, following patients for a longer period of time and gathering additional data on how our biomarker tracks the infection process from early onset to progression to a patient's…
University of Wisconsin News highlights the potential value of Isomark's non-invasive technology, particularly in a world where antibiotic-resistant infections are an escalating issue. And although the article focuses primarily on the use of Isomark's Canary for bacterial infections, since the device is looking at a shift in the body's response to an infection and how it metabolizes different isotopes, it will be useful for viral and fungal infections as well. Read more here!
A video produced by the UW-Madison Athletic Department has highlighted the football team’s continuing trial of “Energy Balance,” a test that may lead to better ways to optimize athletes’ training. The video describes how ‘Energy Balance’ is being used to monitor individualized performance by about 30 members of the football team. According to researchers at Madison-based Isomark LLC, the technology can provide immediate feedback for weight gain or loss as well as other health-related uses by measuring the carbon in exhaled breath. “From a performance team standpoint, this information is vital, because ultimately we want to put (players) in a position to succeed on and off the field,” said Jamil Walker, the Wisconsin football team’s assistant strength and condition coach. “We can look at what their body is using for energy…
Isomark's Chief Scientific Officer, Dr. Dan Bütz, was featured in an episode of WisBusiness: The Show, a twice-a-month web show covering state business news and issues. Watch it now! This episode highlights Dr. Butz's journey with Isomark from the world of R&D into the startup economy.
Click "Isomark Newsletter - July 2015" to read the July newsletter. Isomark’s newsletters come out a few times throughout the year. If you don’t want to miss another Isomark newsletter, please sign-up to receive all the newsletters here: http://isomark.com/contact-us/. We promise to never spam you.
Breathalyzers can be used for so much more than determining alcohol in the body. This article features Isomark's latest development with its Canary device and its potential application toward weight management. Read more here from MedCityNews: Four cool and unique breathalyzer applications.
Isomark made front-page news of the Wisconsin State Journal's Business section. The Canary can do more than identify if someone has an infection; it can show if your body has an energy surplus or deficit. Read the full article here: Madison firm's breath analyzer can tell if you're about to gain weight